Cargando…

Effects of intravenous administration of magnesium sulfate in propofol-based sedation for ERCP in elderly patients: a randomized, double-blind, placebo-controlled study

BACKGROUND: Propofol-based sedations are widely used in elderly patients for endoscopic retrograde cholangiopancreatography (ERCP) procedure, but respiratory depression and cardiovascular adverse events commonly occur. Magnesium administered intravenously can alleviate pain and decrease propofol req...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jie, Qian, Ke, Liu, Chun-hong, Li, Xiao-li, Chen, Yan, Wang, Jin-quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326926/
https://www.ncbi.nlm.nih.gov/pubmed/37420201
http://dx.doi.org/10.1186/s12877-023-04107-6
_version_ 1785069525979365376
author Chen, Jie
Qian, Ke
Liu, Chun-hong
Li, Xiao-li
Chen, Yan
Wang, Jin-quan
author_facet Chen, Jie
Qian, Ke
Liu, Chun-hong
Li, Xiao-li
Chen, Yan
Wang, Jin-quan
author_sort Chen, Jie
collection PubMed
description BACKGROUND: Propofol-based sedations are widely used in elderly patients for endoscopic retrograde cholangiopancreatography (ERCP) procedure, but respiratory depression and cardiovascular adverse events commonly occur. Magnesium administered intravenously can alleviate pain and decrease propofol requirements during surgery. We hypothesized that intravenous magnesium was used as adjuvant to propofol might be beneficial in elderly patients undergoing ERCP procedures. METHODS: Eighty patients aged from 65 to 79 years who were scheduled for ERCP were enrolled. All patients were intravenously administered 0.1 µg/kg sufentanil as premedication. The patients were randomized to receive either intravenous magnesium sulfate 40 mg/kg (group M, n = 40) or the same volume of normal saline (group N, n = 40) over 15 min before the start of sedation. Intraoperative sedation was provided by propofol. Total propofol requirement during ERCP was the primary outcome. RESULTS: The total propofol consumption were reduced by 21.4% in the group M compared with the group N (151.2 ± 53.3 mg vs. 192.3 ± 72.1 mg, P = 0.001). The incidences of respiratory depression episodes and involuntary movement were less in the group M than those in the group N (0/40 vs. 6/40, P = 0.011; 4/40 vs. 11/40, P = 0.045; respectively). In the group M, the patients experienced less pain than those in the group N at 30 min after the procedure (1 [0–1] vs. 2 [1–2], P < 0.001). Correspondingly, the patients’ satisfaction was clearly higher in the group M (P = 0.005). There was a tendency towards lower intraoperative heart rate and mean arterial pressure in group M. CONCLUSIONS: A single bolus of 40 mg/kg of intravenous magnesium can significantly reduce propofol consumption during ERCP, with higher sedation success and lower adverse events. TRIAL REGISTRATION: ID UMIN000044737. Registered 02/07/2021.
format Online
Article
Text
id pubmed-10326926
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103269262023-07-08 Effects of intravenous administration of magnesium sulfate in propofol-based sedation for ERCP in elderly patients: a randomized, double-blind, placebo-controlled study Chen, Jie Qian, Ke Liu, Chun-hong Li, Xiao-li Chen, Yan Wang, Jin-quan BMC Geriatr Research BACKGROUND: Propofol-based sedations are widely used in elderly patients for endoscopic retrograde cholangiopancreatography (ERCP) procedure, but respiratory depression and cardiovascular adverse events commonly occur. Magnesium administered intravenously can alleviate pain and decrease propofol requirements during surgery. We hypothesized that intravenous magnesium was used as adjuvant to propofol might be beneficial in elderly patients undergoing ERCP procedures. METHODS: Eighty patients aged from 65 to 79 years who were scheduled for ERCP were enrolled. All patients were intravenously administered 0.1 µg/kg sufentanil as premedication. The patients were randomized to receive either intravenous magnesium sulfate 40 mg/kg (group M, n = 40) or the same volume of normal saline (group N, n = 40) over 15 min before the start of sedation. Intraoperative sedation was provided by propofol. Total propofol requirement during ERCP was the primary outcome. RESULTS: The total propofol consumption were reduced by 21.4% in the group M compared with the group N (151.2 ± 53.3 mg vs. 192.3 ± 72.1 mg, P = 0.001). The incidences of respiratory depression episodes and involuntary movement were less in the group M than those in the group N (0/40 vs. 6/40, P = 0.011; 4/40 vs. 11/40, P = 0.045; respectively). In the group M, the patients experienced less pain than those in the group N at 30 min after the procedure (1 [0–1] vs. 2 [1–2], P < 0.001). Correspondingly, the patients’ satisfaction was clearly higher in the group M (P = 0.005). There was a tendency towards lower intraoperative heart rate and mean arterial pressure in group M. CONCLUSIONS: A single bolus of 40 mg/kg of intravenous magnesium can significantly reduce propofol consumption during ERCP, with higher sedation success and lower adverse events. TRIAL REGISTRATION: ID UMIN000044737. Registered 02/07/2021. BioMed Central 2023-07-07 /pmc/articles/PMC10326926/ /pubmed/37420201 http://dx.doi.org/10.1186/s12877-023-04107-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Jie
Qian, Ke
Liu, Chun-hong
Li, Xiao-li
Chen, Yan
Wang, Jin-quan
Effects of intravenous administration of magnesium sulfate in propofol-based sedation for ERCP in elderly patients: a randomized, double-blind, placebo-controlled study
title Effects of intravenous administration of magnesium sulfate in propofol-based sedation for ERCP in elderly patients: a randomized, double-blind, placebo-controlled study
title_full Effects of intravenous administration of magnesium sulfate in propofol-based sedation for ERCP in elderly patients: a randomized, double-blind, placebo-controlled study
title_fullStr Effects of intravenous administration of magnesium sulfate in propofol-based sedation for ERCP in elderly patients: a randomized, double-blind, placebo-controlled study
title_full_unstemmed Effects of intravenous administration of magnesium sulfate in propofol-based sedation for ERCP in elderly patients: a randomized, double-blind, placebo-controlled study
title_short Effects of intravenous administration of magnesium sulfate in propofol-based sedation for ERCP in elderly patients: a randomized, double-blind, placebo-controlled study
title_sort effects of intravenous administration of magnesium sulfate in propofol-based sedation for ercp in elderly patients: a randomized, double-blind, placebo-controlled study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326926/
https://www.ncbi.nlm.nih.gov/pubmed/37420201
http://dx.doi.org/10.1186/s12877-023-04107-6
work_keys_str_mv AT chenjie effectsofintravenousadministrationofmagnesiumsulfateinpropofolbasedsedationforercpinelderlypatientsarandomizeddoubleblindplacebocontrolledstudy
AT qianke effectsofintravenousadministrationofmagnesiumsulfateinpropofolbasedsedationforercpinelderlypatientsarandomizeddoubleblindplacebocontrolledstudy
AT liuchunhong effectsofintravenousadministrationofmagnesiumsulfateinpropofolbasedsedationforercpinelderlypatientsarandomizeddoubleblindplacebocontrolledstudy
AT lixiaoli effectsofintravenousadministrationofmagnesiumsulfateinpropofolbasedsedationforercpinelderlypatientsarandomizeddoubleblindplacebocontrolledstudy
AT chenyan effectsofintravenousadministrationofmagnesiumsulfateinpropofolbasedsedationforercpinelderlypatientsarandomizeddoubleblindplacebocontrolledstudy
AT wangjinquan effectsofintravenousadministrationofmagnesiumsulfateinpropofolbasedsedationforercpinelderlypatientsarandomizeddoubleblindplacebocontrolledstudy